Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06046651 · ClinicalTrials.gov registry record

Blood Specimen Collection For Laboratory Assay Research

A clinical trial of Sexual Dysfunction and Hair Loss, sponsored by Roman Health Ventures.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT06046651 is a study of Sexual Dysfunction and Hair Loss that is actively recruiting participants, run by Roman Health Ventures. The registered enrollment target is 10,000 participants, above the 468-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (2037% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06046651, a study of Sexual Dysfunction and Hair Loss, is actively recruiting participants, sponsored by Roman Health Ventures.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

To collect lab data from capillary and venous blood specimens for use in analytical research studies to support the development and validation of laboratory procedures.

Study Locations (1)

California

  • Roman Health Ventures Study Site - San Francisco

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2023-08-16
Est. Completion 2033-08-15

Sponsor

Roman Health Ventures

1 total trials

What the Registry Record Tells You About NCT06046651

The ClinicalTrials.gov registry entry for NCT06046651 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 468-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (2037% higher). The listed sponsor is Roman Health Ventures, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Sexual Dysfunction appearing as the primary indexed condition, and to 0 interventions.

NCT06046651 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06046651 about?

NCT06046651 is a clinical study titled "Blood Specimen Collection For Laboratory Assay Research". To collect lab data from capillary and venous blood specimens for use in analytical research studies to support the development and validation of laboratory procedures.

What is the current status of trial NCT06046651?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2023-08-16. Estimated completion is 2033-08-15.

What conditions does trial NCT06046651 study?

This clinical trial studies the following conditions: Sexual Dysfunction, Hair Loss, Pathology, General; Metabolic Disorder.

Who is sponsoring clinical trial NCT06046651?

This trial is sponsored by Roman Health Ventures, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06046651 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sexual Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.